A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice Marina SimianTeresita ManzurSlobodanka Klein Preclinical Study 09 January 2008 Pages: 1 - 8
2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells? Samar S. AzabSalama A. SalamaAyman Al-Hendy Preclinical Study 29 January 2008 Pages: 9 - 19
Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21 Kathryn A. SkeldingRichard D. BarryDarren R. Shafren Preclinical Study 07 February 2008 Pages: 21 - 30
25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture Xinjian PengMichael HawthorneRajendra G. Mehta Preclinical Study 20 January 2008 Pages: 31 - 41
Evidence for a role of the Simian Virus 40 in human breast carcinomas M. HachanaM. TrimecheS. Korbi Preclinical Study 18 January 2008 Pages: 43 - 58
Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast Andrew R. GreenSophie KrivinskasIan O. Ellis Preclinical Study 23 January 2008 Pages: 59 - 66
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? Antonio RussoValentina CalòViviana Bazan Preclinical Study 29 January 2008 Pages: 67 - 70
A novel BRCA1 mutation in a Spanish patient with ovarian cancer Josefa SalgadoCarmen GilJesús García-Foncillas Preclinical Study 17 February 2008 Pages: 71 - 73
Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer Kirsimari AaltonenRose-Marie AminiCarl Blomqvist Preclinical Study 01 February 2008 Pages: 75 - 82
Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients Young Jin ChoiYoon La ChoiSeok Jin Nam Preclinical Study 29 January 2008 Pages: 83 - 93
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity Andrew L. CovelerVivian GoodellMary L. Disis Preclinical Study 31 January 2008 Pages: 95 - 100
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model Kathryn N. PhoenixFrank VumbacaKevin P. Claffey Preclinical Study 07 February 2008 Pages: 101 - 111
RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression Manish Mani SubramaniamJason Yongsheng ChanThomas Choudary Putti Preclinical Study 07 February 2008 Pages: 113 - 121
Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed Hirofumi MukaiToru WatanabeNoriyuki Katsumata Clinical Trial 10 January 2008 Pages: 123 - 128
Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study Igor LangerUlrich GullerFor the Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer Clinical Trial 23 February 2008 Pages: 129 - 136
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93 Beat ThürlimannKaren N. PriceAron Goldhirsch Clinical Trial 08 February 2008 Pages: 137 - 144
Increase in response rate by prolonged treatment with neoadjuvant letrozole J. Michael DixonLorna RenshawWilliam R. Miller Clinical Trial 09 February 2008 Pages: 145 - 151
Joint effects of body size, energy intake, and physical activity on breast cancer risk Aesun ShinCharles E. MatthewsWei Zheng Epidemiology 29 January 2008 Pages: 153 - 161
Effect of a low-fat, high-carbohydrate dietary intervention on change in mammographic density over menopause Lisa J. MartinCarolyn V. GreenbergNorman F. Boyd Epidemiology 23 January 2008 Pages: 163 - 172
Stage migration due to introduction of the sentinel node procedure: a population-based study A. J. G. MaaskantL. V. van de Poll-FranseG. A. P. Nieuwenhuijzen Epidemiology 08 February 2008 Pages: 173 - 179
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive Ben Van CalsterIsabelle Vanden BemptPatrick Neven Epidemiology 09 February 2008 Pages: 181 - 187
Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program W. F. AndersonS. LuoM. E. Sherman Epidemiology 07 February 2008 Pages: 189 - 196
Association of polymorphisms of angiogenesis genes with breast cancer H. ClarP. KripplU. Langsenlehner Letter to the editor 22 January 2008 Pages: 197 - 198